Clinical Trial

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, observational registry for subjects with SLE under the care of a rheumatology provider. Longitudinal data are collected from both subjects and their treating rheumatology provider during routine clinical encounters using a structured and standardized data collection method.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-30; most recent amendment 2026-02-05.
Status change: Enrolling by Invitation → Recruiting 2025-09-29
Trial Details
NCT Number NCT06804057
Lead Sponsor CorEvitas
Conditions Systemic Lupus Erythematosus
Enrollment 1,000 participants
Start Date 2024-09-26
Primary Completion 2099-12-31 (estimated)
Study Completion 2099-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06